Yellow Fever Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
Yellow fever is essentially a mosquito-borne disease, which is more prevalent in African countries as well as in Central and South American region. Often, these diseases are transmitted across the countries via infected travelers, but it is more frequent in countries wherein the mosquito species are able to flourish in a region’s specific climatic conditions and the animal pool required to maintain their prosperity. In 2017, Brazil has notified more than half a dozen separate cases of yellow fever across the country and its prevalence continues to mount in different parts of the world too. As a result, the demand in the global yellow fever treatment market is expected to expand at a steady rate during the forecast period of 2017 to 2025.
Factors such as unhygienic lifestyle, increasing awareness among people pertaining to the availability of the treatment to cure yellow fever, improving healthcare infrastructure in several emerging economies, growing number of international travelers, and increased efforts from health organizations such as the UNICEF and the World Health Organization (WHO) are some of the factors augmenting the demand in the global yellow fever treatment market. UNICEF already procures nearly 34 million yellow fever vaccination doses per year and has long-term agreements with four drug companies to provide the vaccination required for routine programmers, emergency, and preventive campaigns. Still, the supply is significantly insufficient to meet the increasing demand, and hence the demand in the global yellow fever treatment market is expected to swell consistently over the course of next few years.
Yellow fever is caused by a virus transferred through infected Aedes aegypti mosquitoes. These mosquitoes thrive near human dwellings and breed in clean waters. The occurrence of yellow fever is more prevalent in sub-Saharan Africa and tropical South America. Humans and monkeys represent the target patient population infected with yellow fever virus.
Yellow fever infection can be lethal as it damages the liver and other internal organs. As per statistics of the World Health Organization, yellow fever affects more than 200,000 individuals every year, of which 90% are reported in Africa. These cases result in 30,000 deaths every year. Factors such as decreasing immunity among the local population, deforestation, and high-density urbanization increases the risk of yellow fever across the world.
The report represents facts and figures pertaining to the global yellow fever treatment market in a chronological order. With a scrutiny of past data and current market trends, analysts present a satisfactory picture regarding the market’s future. The users of the report, therefore, receive accurate projections of the global yellow fever treatment market that can be used to formulate cutting-edge business strategies for the future. Using validated analytical tools such as Porter’s Five Forces analysis and SWOT analysis, the report presents valuable insights about the strengths, weakness, opportunities, and threats of the market until the end of the forecast period in 2025.
A detailed analysis of the current competitive landscape is included in the report. The section includes a competitive profile of the leading players and an analysis of their strengths, weakness, opportunities, and threats for the 2017-2025 period.
The prevention of yellow fever is essential and vaccination is advised for children above 9 months of age. These vaccines are usually administered by travel medicine clinics and local or state health departments and needs to be repeated every 10 years for individuals who travel frequently to high risk African and Latin American countries.
Individuals with compromised immune system or cancer patient, pregnant women, and children below 9 months of age are recommended not to take yellow fever vaccine.
The increasing importance of travel medicine complemented by increasing involvement of respective governments for timely vaccination are the major factors driving the global yellow fever treatment market. However, factors such as demand-supply gap of vaccines and high costs are restraining the growth of this market.
As per data provided by the United Nations International Children’s Emergency Fund (UNICEF), there is a large demand-supply gap for yellow fever vaccines. For instance, the demand exceeded supply by almost 44% for the year 2014-2015 despite procurement of all available vaccines by UNICEF. DiTu, LCTA-949, YF-17D, Flaviviruses infection vaccines represent some of the drugs under clinical trials for yellow fever.
Some of the leading companies operating in the global yellow fever treatment market are Panacea Biotech Limited, Themis Bioscience GmbH, Arbovax Inc., and Janssen Pharmaceutcals Inc. Each of the companies is profiled for their attributes of product portfolio, recent developments, and financial standing.
This study provides a particularized anatomy according to the L.E.A.P mechanism
The regional analysis offers market assays across:
The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.
Latest Trends and Cardinal Growth Prospects
The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.
Existing and Future Insights in Growth
The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.
Ascensions in Technology
Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.
The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.
The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.
An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.
The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!
This report is the key to questions such as:
What are the prominent factors that will help in reshaping the market growth?
Which trends have the potential to bring expansive growth for the market?
What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?
Which regions will emerge as champion growth contributors for the market?
Which aspects will serve as game-changers for the market?
What are the latest innovations in the market?
Which factors will hinder the growth of the market?
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report